189 related articles for article (PubMed ID: 24937051)
21. Evaluation of the effect of acute sibutramine in female rats in the elevated T-maze and elevated plus-maze tests.
Santos RO; de Assunção GL; de Medeiros DM; de Sousa Pinto IA; de Barros KS; Soares BL; André E; Gavioli EC; de Paula Soares-Rachetti V
Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):181-7. PubMed ID: 24034271
[TBL] [Abstract][Full Text] [Related]
22. Effects of chronic corticosterone and imipramine administration on panic and anxiety-related responses.
Diniz L; Dos Reis BB; de Castro GM; Medalha CC; Viana MB
Braz J Med Biol Res; 2011 Oct; 44(10):1048-53. PubMed ID: 21915474
[TBL] [Abstract][Full Text] [Related]
23. Use of the elevated T-maze to study anxiety in mice.
Carvalho-Netto EF; Nunes-de-Souza RL
Behav Brain Res; 2004 Jan; 148(1-2):119-32. PubMed ID: 14684253
[TBL] [Abstract][Full Text] [Related]
24. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior.
Plaza-Zabala A; Martín-García E; de Lecea L; Maldonado R; Berrendero F
J Neurosci; 2010 Feb; 30(6):2300-10. PubMed ID: 20147556
[TBL] [Abstract][Full Text] [Related]
25. Anxiogenic-like effect of corticotropin-releasing factor receptor 2 antisense oligonucleotides infused into rat brain.
Isogawa K; Akiyoshi J; Tsutsumi T; Kodama K; Horinouti Y; Nagayama H
J Psychopharmacol; 2003 Dec; 17(4):409-13. PubMed ID: 14870953
[TBL] [Abstract][Full Text] [Related]
26. GABA/benzodiazepine receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze.
Bueno CH; Zangrossi H; Viana Mde B
Brain Res Bull; 2007 Sep; 74(1-3):134-41. PubMed ID: 17683799
[TBL] [Abstract][Full Text] [Related]
27. Alleviation of the effects of endotoxin exposure on behavior and hippocampal IL-1beta by a selective non-peptide antagonist of corticotropin-releasing factor receptors.
Kohman RA; Tarr AJ; Sparkman NL; Day CE; Paquet A; Akkaraju GR; Boehm GW
Brain Behav Immun; 2007 Aug; 21(6):824-35. PubMed ID: 17339098
[TBL] [Abstract][Full Text] [Related]
28. Corticotropin-releasing factor in ventromedial prefrontal cortex mediates avoidance of a traumatic stress-paired context.
Schreiber AL; Lu YL; Baynes BB; Richardson HN; Gilpin NW
Neuropharmacology; 2017 Feb; 113(Pt A):323-330. PubMed ID: 27235163
[TBL] [Abstract][Full Text] [Related]
29. Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release.
Merali Z; Khan S; Michaud DS; Shippy SA; Anisman H
Eur J Neurosci; 2004 Jul; 20(1):229-39. PubMed ID: 15245495
[TBL] [Abstract][Full Text] [Related]
30. Maternal stress and the MPOA: Activation of CRF receptor 1 impairs maternal behavior and triggers local oxytocin release in lactating rats.
Klampfl SM; Schramm MM; Gaßner BM; Hübner K; Seasholtz AF; Brunton PJ; Bayerl DS; Bosch OJ
Neuropharmacology; 2018 May; 133():440-450. PubMed ID: 29477300
[TBL] [Abstract][Full Text] [Related]
31. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety.
Takahashi LK; Ho SP; Livanov V; Graciani N; Arneric SP
Brain Res; 2001 Jun; 902(2):135-42. PubMed ID: 11384606
[TBL] [Abstract][Full Text] [Related]
32. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Nakazato A; Kumagai T; Okubo T; Tomisawa K
J Pharmacol Exp Ther; 1999 May; 289(2):926-35. PubMed ID: 10215672
[TBL] [Abstract][Full Text] [Related]
33. Picrotoxin blocks the anxiolytic- and panicolytic-like effects of sodium valproate in the rat elevated T-maze.
Dombrowski PA; Fernandes LH; Andreatini R
Eur J Pharmacol; 2006 May; 537(1-3):72-6. PubMed ID: 16626689
[TBL] [Abstract][Full Text] [Related]
34. Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column.
Borelli KG; Brandão ML
Horm Behav; 2008 Jan; 53(1):40-50. PubMed ID: 17920596
[TBL] [Abstract][Full Text] [Related]
35. Influence of procedural variables on rat inhibitory avoidance and escape behaviors generated by the elevated T-maze.
Pobbe RL; Lopes MA; Vasconcelos AT; Yamashita PS; de Bortoli VC; Zangrossi H
Behav Brain Res; 2014 Oct; 273():45-51. PubMed ID: 25066386
[TBL] [Abstract][Full Text] [Related]
36. Environmental enrichment decreases avoidance responses in the elevated T-maze and delta FosB immunoreactivity in anxiety-related brain regions.
Lopes DA; Souza TMO; de Andrade JS; Silva MFS; Antunes HKM; Sueur-Maluf LL; Céspedes IC; Viana MB
Behav Brain Res; 2018 May; 344():65-72. PubMed ID: 29448033
[TBL] [Abstract][Full Text] [Related]
37. 5-HT1A receptors of the lateral septum regulate inhibitory avoidance but not escape behavior in rats.
Viana Mde B; Zangrossi H; Onusic GM
Pharmacol Biochem Behav; 2008 May; 89(3):360-6. PubMed ID: 18282594
[TBL] [Abstract][Full Text] [Related]
38. Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors.
Zorrilla EP; Schulteis G; Ormsby A; Klaassen A; Ling N; McCarthy JR; Koob GF; De Souza EB
Brain Res; 2002 Oct; 952(2):200-10. PubMed ID: 12376180
[TBL] [Abstract][Full Text] [Related]
39. Corticotropin-releasing factor (CRF) receptor subtypes in mediating neuronal activation of brain areas involved in responses to intracerebroventricular CRF and stress in rats.
Takahashi C; Ohata H; Shibasaki T
Peptides; 2011 Dec; 32(12):2384-93. PubMed ID: 21964377
[TBL] [Abstract][Full Text] [Related]
40. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
Deak T; Nguyen KT; Ehrlich AL; Watkins LR; Spencer RL; Maier SF; Licinio J; Wong ML; Chrousos GP; Webster E; Gold PW
Endocrinology; 1999 Jan; 140(1):79-86. PubMed ID: 9886810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
